- Home
- JFU vs GELS Comparison
JFU vs GELS Comparison
Compare JFU & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFU
- GELS
- Stock Information
- Founded
- JFU 2006
- GELS 2018
- Country
- JFU China
- GELS Australia
- Employees
- JFU N/A
- GELS N/A
- Industry
- JFU Finance: Consumer Services
- GELS
- Sector
- JFU Finance
- GELS
- Exchange
- JFU Nasdaq
- GELS NYSE
- Market Cap
- JFU 17.1M
- GELS 15.9M
- IPO Year
- JFU 2019
- GELS 2024
- Fundamental
- Price
- JFU $1.40
- GELS $1.88
- Analyst Decision
- JFU
- GELS
- Analyst Count
- JFU 0
- GELS 0
- Target Price
- JFU N/A
- GELS N/A
- AVG Volume (30 Days)
- JFU 2.9K
- GELS 4.0M
- Earning Date
- JFU 01-01-0001
- GELS 02-15-2025
- Dividend Yield
- JFU N/A
- GELS N/A
- EPS Growth
- JFU N/A
- GELS N/A
- EPS
- JFU 0.09
- GELS N/A
- Revenue
- JFU $40,614,155.00
- GELS $95,618.00
- Revenue This Year
- JFU N/A
- GELS N/A
- Revenue Next Year
- JFU N/A
- GELS N/A
- P/E Ratio
- JFU $15.08
- GELS N/A
- Revenue Growth
- JFU N/A
- GELS N/A
- 52 Week Low
- JFU $1.01
- GELS $0.77
- 52 Week High
- JFU $3.60
- GELS $5.50
- Technical
- Relative Strength Index (RSI)
- JFU 50.23
- GELS N/A
- Support Level
- JFU $1.36
- GELS N/A
- Resistance Level
- JFU $1.48
- GELS N/A
- Average True Range (ATR)
- JFU 0.07
- GELS 0.00
- MACD
- JFU -0.01
- GELS 0.00
- Stochastic Oscillator
- JFU 21.13
- GELS 0.00
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.